Thierry Vernier
Direktor/Vorstandsmitglied bei Bioverativ Therapeutics, Inc.
Profil
Thierry Vernier is currently a Director at Bioverativ Therapeutics, Inc. He previously worked as a Vice President-Financial Control & Plan at Sanofi from 2004 to 2013.
He is a graduate of Ecole de Management de Normandie.
Aktive Positionen von Thierry Vernier
| Unternehmen | Position | Beginn |
|---|---|---|
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Thierry Vernier
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Comptroller/Controller/Auditor | 21.06.2012 |
Ausbildung von Thierry Vernier
| Ecole de Management de Normandie | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SANOFI | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
